As of 18 Sept 2026, Parmax Pharma Ltd share price is ₹135.05. The stock opened at ₹135.05 and had closed at ₹133.75 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹22.60 and a high of ₹135.05. In terms of performance, Parmax Pharma Ltd share price has increased by 351.67% over the past six months and has increased by 310.24% over the last year.
Parmax Pharma Stock Price Chart
Parmax Pharma Ltd Overview
About Parmax Pharma
Parmax Pharma is engaged in the manufacture and supply of bulk drugs (APIs) and selected formulations catering primarily to the Indian pharmaceutical industry.
Parmax Pharma Ltd Historical Performance
Parmax Pharma Ltd Fundamentals
Parmax Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 12.16 | 28.24 | 11.10 | 15.46 | 18.31 |
| EBITDA | -3.60 | -0.78 | -3.33 | 2.30 | 2.62 |
| Net Profit | -4.16 | -2.09 | -5.75 | -0.10 | 0.14 |
| EPS | -11.12 | -5.60 | -15.37 | -0.28 | 0.38 |
Parmax Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 133.75 |
| Resistance 1 (R1) | 133.75 |
| Pivot Point | 133.75 |
Parmax Pharma Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Umang Alkesh Gosalia | Managing Director |
| Ami R Shah | Non Executive Independent Director |
| Nikhil S. Uchat | Non Executive Independent Director |
Parmax Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Parmax Pharma Ltd today is ₹135.05 on NSE and ₹135.05 on BSE.
- The 52-week high of Parmax Pharma Ltd is ₹135.05, while the 52-week low is ₹22.60.
- The current market capitalisation of Parmax Pharma Ltd is approximately ₹93 crore.
- The P/E (Price-to-Earnings) ratio of Parmax Pharma Ltd is -77.61. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Parmax Pharma Ltd is 20.22. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Parmax Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Parmax Pharma on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Parmax Pharma Ltd has delivered a return of approximately 345.71%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Parmax Pharma Ltd comprises different categories of shareholders. As of Sept 2026, the shareholding is approximately 64.66% promoters, 0.00% FIIs, 0.00% DIIs, and 34.74% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
